Cui SJ - Search Results

1

TIM-3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression.

Cui SJ, Li Y, Zhou RM, Liu L, Cao SR, Huang X, Huo XR, Wang N. Cui SJ, et al. Environ Mol Mutagen. 2021 Apr;62(4):273-283. doi: 10.1002/em.22432. Epub 2021 Mar 22. Environ Mol Mutagen. 2021. PMID: 33723872

2

The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.

Wang N, Li Y, Zhou RM, Cui SJ, Cao SR, Huang X, Huo XR, Shan BE. Wang N, et al. Among authors: cui sj. Mutagenesis. 2019 Dec 19;34(4):307-313. doi: 10.1093/mutage/gez012. Mutagenesis. 2019. PMID: 31165868

3

Osimertinib for EGFR-mutant lung cancer with central nervous system metastases: a meta-analysis and systematic review.

Wang N, Zhang Y, Mi Y, Deng H, Chen G, Tang Z, Mao J, Cui S, Zhang Y, Wang L. Wang N, et al. Ann Palliat Med. 2020 Sep;9(5):3038-3047. doi: 10.21037/apm-20-605. Epub 2020 Sep 14. Ann Palliat Med. 2020. PMID: 32954743 Free article.

4

Clinicopathological and prognostic value of circulating tumor cells in esophageal carcinoma: a meta-analysis.

Zhang Y, Deng H, Chen G, Tang Z, Mao J, Mi Y, Cui S, Zhang Y, Wang N, Wang L. Zhang Y, et al. Ann Palliat Med. 2020 Nov;9(6):4271-4282. doi: 10.21037/apm-20-590. Epub 2020 Oct 27. Ann Palliat Med. 2020. PMID: 33183057 Free article.

5

The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis.

Cui S, Zhang Y, Liu L, Li Y, Zhou R, Huang X, Cao S, Huo X, Wang N. Cui S, et al. Ann Palliat Med. 2021 Feb;10(2):1851-1860. doi: 10.21037/apm-20-1357. Epub 2021 Jan 14. Ann Palliat Med. 2021. PMID: 33474947 Free article.

6

CDH1 Gene rs1801552 C/T Polymorphism Increases Susceptibility to Esophageal Squamous Cell Carcinoma but Not to Gastric Cardiac Adenocarcinoma.

Huang X, Li Y, Zhou RM, Cui SJ, Cao SR, Huo XR, Wang N. Huang X, et al. Among authors: cui sj. Cancer Invest. 2021 Nov;39(10):812-818. doi: 10.1080/07357907.2021.1916520. Epub 2021 Oct 8. Cancer Invest. 2021. PMID: 33888005

7

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

Liu L, Cui S, Liu M, Huo X, Zhang G, Wang N. Liu L, et al. Front Cardiovasc Med. 2022 Mar 25;9:829709. doi: 10.3389/fcvm.2022.829709. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35402553 Free PMC article.

8

Corrigendum: Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

Liu L, Cui S, Liu M, Huo X, Zhang G, Wang N. Liu L, et al. Front Cardiovasc Med. 2022 May 13;9:929149. doi: 10.3389/fcvm.2022.929149. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35647042 Free PMC article.

9

The Role of m⁶A Modification and m⁶A Regulators in Esophageal Cancer.

Li Y, Niu C, Wang N, Huang X, Cao S, Cui S, Chen T, Huo X, Zhou R. Li Y, et al. Cancers (Basel). 2022 Oct 20;14(20):5139. doi: 10.3390/cancers14205139. Cancers (Basel). 2022. PMID: 36291923 Free PMC article. Review.

10

Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.

Liu M, Wang H, Liu L, Cui S, Huo X, Xiao Z, Zhao Y, Wang B, Zhang G, Wang N. Liu M, et al. Front Immunol. 2022 Oct 21;13:1046352. doi: 10.3389/fimmu.2022.1046352. eCollection 2022. Front Immunol. 2022. PMID: 36389759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters